This brief review focuses on the functional activities of plasma hemopexin recently recognized by several authors. In particular, the protease-like activity of hemopexin in vitro is linked with downregulation of the vascular angiotensin II receptor in vivo, leading to vascular expansion. Also a potential mechanism of inhibition of hemopexin activity by extracellular adenosine triphosphate is considered.
GrabarPde Vaux St-CyrCCleveH. Presence of β1-B globulin in the perchloric acid extracts of human normal serums. Bull Soc Chim Biol. 1960;42:853–856.
2.
ImmenschuhSSongDXSatohHMuller-EberhardU. The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem Biophys Res Commun. 1995;207(1):202–208.
3.
MorganWTSmithA. Binding and transport of iron-porphyrins by hemopexin. Adv Inorg Chem. 2001;51:205–241.
4.
DelangheJRLangoisMR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta. 2001;312(1-2):13–23.
5.
TolosanoEFagoneeSMorelloMVinchiFFioritoV. Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal. 2010;12(2):305–320.
6.
MarchotPChatonnetA. Enzymatic activity and protein interactions in alpha/beta hydrolase fold proteins: moonlighting versus promiscuity. Protein Pept Lett. 2012;19(2):132–143.
SuzukiKKobayashiNDoiTHijikataTMachidaINamikiH. Inhibition of Mg2+ dependent adhesion of polymorphonuclear leucocytes by serum hemopexin: differences in divalent-cation dependency of cell adhesion in the presence and absence of serum. Cell Struct Funct. 2003;28(4):243–253.
CheungPKStulpBImmenschuhSBorghuisTBallerJFBakkerWW. Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol. 1999;10(8):1700–1708.
12.
BakkerWWBorghuisTHarmsenMCProtease activity of plasma hemopexin. Kidney Int. 2005;68(2):603–610.
13.
ManganMSKaisemanDBirdPI. The role of serpins in vertebrate immunity. Tissue Antigens. 2008;72(1):1–10.
14.
ColmanRW. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, anti-adhesive and anti-angiogenic activities. In: ComanRWHirshJMarderVJClowesAWGeorgeJN, eds. Hemostasis and Thrombosis; Basic Principles and Clinical Practice. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:103–121.
15.
BakkerWWHenningRHvan SonWJVascular contraction and preeclampsia: down-regulation of the angiotensin receptor 1 by hemopexin in vitro. Hypertension. 2009;53(6):959–964.
16.
BakkerWWDonkerRBTimmerAPlasma hemopexin activity in pregnancy and preeclampsia. Hypertens Pregnancy. 2007;26(2):227–239.
17.
SpillerFCostaCSoutoFOInhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice. Am J Respir Crit Care Med. 2011;183(7):922–931.
18.
GrantNFDaleyGLChandSWhalleyPJMacDonaldPC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52(11):2682–2689.
19.
MitchellRNSchoenJ. Blood vessels. In: KumarVAbbasAKFaustoNAsterJC, eds. The Pathologic Basis of Diseases. Philadelphia, Pa: Saunders Elsevier; 2010:487–529.
20.
CheungPKKlokPABakkerWW. Minimal change-like glomerular alterations induced by a human plasma factor. Nephron. 1996;74(3):586–593.
21.
BakkerWWvan DaelCMPierikLJAltered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol. 2005;20(10):1410–1415.
22.
CheungPKKlokPABallerJFBakkerWW. Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int. 2000;57(4):1512–1520.
23.
KapojosJJPoelstraKBorghuisTBanasBBakkerWW. Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells. Nephron Physiol. 2004;96(1):1–10.
24.
MaukMRSmithAMaukAG. An alternative view of the proposed alternative activities of hemopexin. Protein Sci. 2011;20(5):791–805.
25.
DunkerAKKriwackiRW. The orderly chaos of proteins. Sci Am. 2011;304(4):68–73.
26.
ChouardT. Breaking the protein rules. Nature. 2011;471(7337):151–153.
27.
WangYFisherJCMathewRIntrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Nat Chem Biol. 2011;7(4):214–221.
